Cafepharma Today

September 16 2024 - Novartis’ breast cancer trial of Kisqali reveals 28.5% risk reduction
Novartis’ breast cancer trial of Kisqali reveals 28.5% risk reduction
ESMO: Bayer hopes to expand Nubeqa's prostate cancer reach with chemo-free regimen
Biopharma prepares to pivot from China as Biosecure Act advances
ESMO: Bristol Myers axes Immatics' bispecific after $150M bet
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

5-Star Stocks Poised to Pop: Genzyme
Motley Fool
Thursday, October 23, 2008 - 11:11am
tags:
Amgen, Bristol-Myers, Lilly lead drug stocks higher
Marketwatch
Thursday, October 23, 2008 - 11:09am
tags:
Wyeth Trades at Fair Value
Yahoo/Zacks.com
Thursday, October 23, 2008 - 11:08am
tags:
Pfizer & Lilly Prove Me Wrong
CNBC
Thursday, October 23, 2008 - 11:07am
tags:
FDA Watch: Painkillers on the Fall/Winter Agenda
Seeking Alpha
Thursday, October 23, 2008 - 11:05am
tags:
Opportunity Knocks: Pharma Stocks
CNBC
Thursday, October 23, 2008 - 11:01am
tags:
Another Drug Maker to Report Payments to Doctors
WSJ Online
Thursday, October 23, 2008 - 9:42am
tags:
Gardasil Vaccine Not Linked to Serious Side Effects
WSJ Online
Thursday, October 23, 2008 - 9:41am
tags:
Big Pharma Feels Free Market Pain
Seeking Alpha
Thursday, October 23, 2008 - 9:40am
tags:
Eli Lilly posts 3Q loss on Zyprexa settlement
Yahoo/AP
Thursday, October 23, 2008 - 9:14am
tags:
Bristol-Myers Profit Falls on Charge From Investment Losses
Bloomberg
Thursday, October 23, 2008 - 9:14am
tags:
Illuminating Illumina
Motley Fool
Thursday, October 23, 2008 - 9:13am
tags:
Amgen reports dramatically higher earnings on charges
Marketwatch
Thursday, October 23, 2008 - 9:12am
tags:
Elan Narrows Loss as Sales of MS Drug Tysabri Double
Bloomberg
Thursday, October 23, 2008 - 9:08am
tags:
Scientists Find Second Gene That Foils ImClone Drug
Bloomberg
Thursday, October 23, 2008 - 9:07am
tags:
Lilly & Co. Provides Support to Amylin
Yahoo/Zacks.com
Wednesday, October 22, 2008 - 12:06pm
tags:
M&A dead? Not for big pharmaceutical companies
Reuters
Wednesday, October 22, 2008 - 12:01pm
tags:
Glaxo Beats Market Chaos
Forbes
Wednesday, October 22, 2008 - 11:58am
tags:
Novartis won't sell Biaxin XL copy
Fierce Pharma
Wednesday, October 22, 2008 - 11:57am
tags:
Merck Shows "Sensitivity" Amid Massive Cuts
CNBC
Wednesday, October 22, 2008 - 11:54am
tags:

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

Informa Connect's Patient Support Services Congress
Drug Channels
Pharma Pulse 9/16/24: Overcoming the Challenges of PBMs, Hopeful News for Users of ADHD Drug & more
pharmexec
Telehealth & Its Role in Providing Access to Weight Loss Drugs
pharmexec
FDA Approves First OTC Hearing Aid Software
pharmexec
Alex Therapeutics and Navamedic Partner For Companion App for Parkinson’s Treatment
pharmexec
Biopharma Must Transform its Payer Launch Playbook
pharmexec
A Risk-Reward Reset: Getting Serious About Social Media
pharmexec
Gilead's Lenacapavir Reduces HIV Infections by 96%, Surpassing Truvada in Twice-Yearly PrEP Treatment
pharmexec
Copay Adjustment Chess Match: What Will Payers Do Next?
pharmexec

Latest Jobs

Account Manager-Los Angeles-Ophthalmics
Los Angeles, California, 90079
Sun Pharmaceutical Industries, Inc.
Regional Sales Manager - Eyecare - East Region
Miami, Florida, 33222
PV8 US Innovex Inc.
Business Development Manager- Tampa, Florida
Tampa, Florida, 33646
Hanger Clinic
Neuroscience Account Manager (Psychiatry) - Burbank, CA
Burbank, California, 91520
Vanda Pharmaceuticals
Territory Account Associate- Grand Rapids, MI
Grand Rapids, Michigan, 49528
Amplity Health
Surgical Solutions Field Sales Associate - Remote
Milwaukee, Wisconsin, 53244
W.L. Gore & Associates
Manager, Business Development - Physician Relations - Days - Full-Time
Baton Rouge, Louisiana, 70873
Woman's Hospital
Area Business Manager - Pulmonology - Greenville, SC
Asheville, North Carolina, 28814
Sanofi
Area Manager, Specialty Atlantic Region
Fields, Oregon, 97710
CSL Behring
Territory Manager (PCP) (Madison, AL)
Huntsville, Alabama, 35824
Bausch Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information